Previous close | 2.4200 |
Open | 1.2500 |
Bid | 1.3000 |
Ask | 2.8500 |
Strike | 490.00 |
Expiry date | 2024-12-20 |
Day's range | 1.2500 - 1.5500 |
Contract range | N/A |
Volume | |
Open interest | 129 |
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.